Evidence map›Paper›PMID 24196705›Full record

ArticleNature2013

HIV-1 evades innate immune recognition through specific cofactor recruitment.

Jane Rasaiyaah, Choon Ping Tan, Adam J Fletcher, Amanda J Price, Caroline Blondeau, Laura Hilditch, David A Jacques, David L Selwood, Leo C James, Mahdad Noursadeghi and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 331 papers.

0numbers the graph read from it
0cells of the map it votes in
331citing papers in PubMed
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

331 citing papers in PubMed, 454 citations in OpenAlex.

  1. Review
  2. Article
  3. Retroviruses use different IPNature communications · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. MX2 Mediates Collapse of the HIV-1 Capsid.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

271 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jane RasaiyaahUniversity College London, Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, 90 Gower St, London WC1E 6BT, United Kingdom.
Choon Ping TanUniversity College London, Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, 90 Gower St, London WC1E 6BT, United Kingdom.
Adam J FletcherUniversity College London, Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, 90 Gower St, London WC1E 6BT, United Kingdom.
Amanda J PriceProtein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
Caroline BlondeauUniversity College London, Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, 90 Gower St, London WC1E 6BT, United Kingdom.
Laura HilditchUniversity College London, Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, 90 Gower St, London WC1E 6BT, United Kingdom.
David A JacquesProtein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
David L SelwoodWolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.
Leo C JamesProtein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
Mahdad Noursadeghi *University College London, Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, 90 Gower St, London WC1E 6BT, United Kingdom.
Greg J Towers *University College London, Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, 90 Gower St, London WC1E 6BT, United Kingdom.
University College London · GBMRC Laboratory of Molecular Biology · GBMedical Research Council · GB

Funding

Medical Research Council G0501446Medical Research Council G0801172Medical Research Council G0900950Medical Research Council G9721629Medical Research Council MC_PC_12024Medical Research Council MC_U105181010Wellcome Trust 090940
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV)-1 is able to replicate in primary human macrophages without stimulating innate immunity despite reverse transcription of genomic RNA into double-stranded DNA, an activity that might be expected to trigger innate pattern recognition receptors. We reasoned that if correctly orchestrated HIV-1 uncoating and nuclear entry is important for evasion of innate sensors then manipulation of specific interactions between HIV-1 capsid and host factors that putatively regulate these processes should trigger pattern recognition receptors and stimulate type 1 interferon (IFN) secretion. Here we show that HIV-1 capsid mutants N74D and P90A, which are impaired for interaction with cofactors cleavage and polyadenylation specificity factor subunit 6 (CPSF6) and cyclophilins (Nup358 and CypA), respectively, cannot replicate in primary human monocyte-derived macrophages because they trigger innate sensors leading to nuclear translocation of NF-κB and IRF3, the production of soluble type 1 IFN and induction of an antiviral state. Depletion of CPSF6 with short hairpin RNA expression allows wild-type virus to trigger innate sensors and IFN production. In each case, suppressed replication is rescued by IFN-receptor blockade, demonstrating a role for IFN in restriction. IFN production is dependent on viral reverse transcription but not integration, indicating that a viral reverse transcription product comprises the HIV-1 pathogen-associated molecular pattern. Finally, we show that we can pharmacologically induce wild-type HIV-1 infection to stimulate IFN secretion and an antiviral state using a non-immunosuppressive cyclosporine analogue. We conclude that HIV-1 has evolved to use CPSF6 and cyclophilins to cloak its replication, allowing evasion of innate immune sensors and induction of a cell-autonomous innate immune response in primary human macrophages.

Indexed as

Immune EvasionCapsid ProteinsCyclophilinsCyclosporineHIV-1HIV InfectionsHumansImmunity, InnateInterferon Regulatory Factor-3Interferon Type IMacrophagesMolecular ChaperonesMonocytesmRNA Cleavage and Polyadenylation FactorsNF-kappa BNuclear Pore Complex ProteinsCapsid Proteinscleavage factor Im, humanCyclophilinsCyclosporineInterferon Regulatory Factor-3Interferon Type IIRF3 protein, humanMolecular ChaperonesmRNA Cleavage and Polyadenylation FactorsNF-kappa BNuclear Pore Complex Proteinsran-binding protein 2Receptors, Pattern Recognition

Identifiers

PMID24196705
PMCPMC3928559
OpenAlexW2077915242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.